Acasti Pharma | ACST - Ebit





Ebit Veränderung Datum
Acasti Pharma USD -3.7M 1.13M 2024-12
Addus HomeCare USD 42.28M 9.34M 2025-12
Amarin USD -1.7M 8.47M 2025-09
Cassava Sciences USD -11.86M 33.53M 2025-09
Knight Therapeutics CAD 2.94M 2.4M 2025-09
Option Care Health USD 91.5M 6.99M 2025-12
Organigram Holdings CAD -28.05M 25.94M 2025-09
Tilray USD -20.01M 9.34M 2025-09